Abstract | OBJECTIVE: METHODS: We evaluated 24 patients ranging from 7 to 16 years of age who took MPH for 6 months. Inclusion criteria were at least two epileptic seizures in the previous 6 months and a diagnosis of ADHD based on DSM-IV criteria. CONCLUSION: Patients were classified according to ADHD subtype as follows: 41.7% inattentive type, 37.5% combined, and 20.8% hyperactive/impulsive type; 58.3% had partial epilepsy and 41.7% generalized epilepsy. There was an overall improvement in ADHD symptoms in 70.8% of patients, and there was no increase in frequency of epileptic seizures in 22 patients (91.6%).
|
Authors | Julio A S Koneski, Erasmo B Casella, Fábio Agertt, Maria Gabriela Ferreira |
Journal | Epilepsy & behavior : E&B
(Epilepsy Behav)
Vol. 21
Issue 3
Pg. 228-32
(Jul 2011)
ISSN: 1525-5069 [Electronic] United States |
PMID | 21524941
(Publication Type: Journal Article, Review)
|
Copyright | Copyright © 2011 Elsevier Inc. All rights reserved. |
Chemical References |
- Central Nervous System Stimulants
- Methylphenidate
|
Topics |
- Adolescent
- Attention Deficit Disorder with Hyperactivity
(complications, drug therapy, epidemiology)
- Brazil
(epidemiology)
- Central Nervous System Stimulants
(therapeutic use)
- Child
- Drug Evaluation
- Electroencephalography
- Female
- Follow-Up Studies
- Humans
- Male
- Methylphenidate
(therapeutic use)
- Psychiatric Status Rating Scales
- Seizures
(complications, drug therapy)
- Time Factors
- Treatment Outcome
|